My ExportersIndia

For Buyer

For Seller

For Help

Medicant Healthcare
gstGST : 07ABEFM6994Q2Z7 5.0/5

Our Products

  1. Medicines Tonics And Drugs 30 Products available
  2. Medical Supplies 10 Products available
  3. Anti Cancer Medicine 5 Products available
  4. Cancer, TB & Tumour Drugs 4 Products available
  5. Pharmaceutical Medicine 3 Products available
  6. Arthritic Drugs 2 Products available
  7. Pharmaceutical Chemical 1 Products available
  8. Pharmaceutical Injectables 1 Products available
  9. Surgical Needles & Scissors 1 Products available
  10. Emulsifiers 1 Products available
  11. Pharmaceutical Capsules 1 Products available
  12. Pharmaceutical Syrups 1 Products available
  13. Anti Infective Medicines & Drugs 1 Products available
  14. Others Products 1 Products available

Pharmaceutical Capsules

Leading Manufacturer, Supplier & Retailer of Ceritinib Hard Gelatin Capsules.

Ceritinib Hard Gelatin Capsules

  • Form Hard Gelatin Capsules
  • Treatment Cancer Treatment
  • Dosage As per Doctor's Prescription
  • Storage Cool and Dry Place
  • Best Before 36 Months from Manufacturing

A drug used to treat adults with non-small cell lung cancer that has spread and is ALK positive. It is also being studied in the treatment of other types of cancer. Ceritinib blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Ceritinib is a type of tyrosine kinase inhibitor. Also called Zykadia. US Brand Name(s): Zykadia. FDA Approved: Yes

 

Ceritinib is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014.

 

Ceritinib is an anaplastic lymphoma kinase (ALK) inhibitor primarily used for the treatment of ALK positive metastatic NSCLC.[4][5] Previously, it was only indicated for patients who had developed resistant to crizotinib, another ALK inhibitor, but has since had its usage expanded to serve as a primary option for metastatic NSCLC.

 

Ceritinib is approved to treat: Non-small cell lung cancer that is ALK positive and has metastasized (spread to other parts of the body). It is used in adults.

View Complete Details
Tell Us What are you looking for? Will call you back

Contact Us